Utility and Drawbacks of Chimeric Antigen Receptor T Cell (CAR-T) Therapy in Lung Cancer

Utility and Drawbacks of Chimeric Antigen Receptor T Cell (CAR-T) Therapy in Lung Cancer

The present treatments for lung cancer include surgical resection, radiation, chemotherapy, targeted therapy, and immunotherapy. Despite advances in therapies, the prognosis of lung cancer has not been substantially improved in recent years. Chimeric antigen receptor (CAR)-T cell immunotherapy has a...

Full description

Bibliographic Details
Main Authors: Prameela Kandra, Rajender Nandigama, Bastian Eul, Magdalena Huber, Sebastian Kobold, Werner Seeger, Friedrich Grimminger, Rajkumar Savai
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-06-01
Series:Frontiers in Immunology
Subjects:
adaptive therapy
CAR-T cells
lung cancer
tumor-associated target antigens
toxicities
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2022.903562/full

Internet

https://www.frontiersin.org/articles/10.3389/fimmu.2022.903562/full

Similar Items